Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/25/2011 | CA2395499C Chlamydia antigens and corresponding dna fragments and uses thereof |
10/20/2011 | WO2011130544A2 Monitoring a dynamic system by liquid chromatography-mass spectrometry |
10/20/2011 | WO2011130305A2 Method for displaying antibodies |
10/20/2011 | WO2011129462A2 A YEAST EXTRACT CONTAINING γ-Glu-X OR γ-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME |
10/20/2011 | WO2011129379A1 Novel anti-hsp90 monoclonal antibody |
10/20/2011 | WO2011128377A1 Method for the selection of a long-term producing cell |
10/20/2011 | WO2010076361A8 Inclusion bodies, bacterial cells and compositions containing them and uses thereof |
10/20/2011 | US20110258710 Methods of Modifying Eukaryotic Cells |
10/20/2011 | US20110257373 Ligands that have binding specificity for dc-sign |
10/20/2011 | US20110257083 Msp-1 protein preparations from plasmodium |
10/20/2011 | US20110257027 Gamma-secretase substrate and methods of use |
10/20/2011 | US20110256620 Nucleic acid encoding a self-assembling split-fluorescent protein system |
10/20/2011 | US20110256587 High affinity human antibodies to human nerve growth factor |
10/20/2011 | US20110256586 Methods and Compositions for the Prevention and Treatment of Anemia |
10/20/2011 | US20110256571 Proteins |
10/20/2011 | US20110256533 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
10/20/2011 | US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site |
10/20/2011 | US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use |
10/20/2011 | US20110256168 Conjugates that Contain the Homeodomain of Antennapedia |
10/20/2011 | US20110256154 Anti-erbb3 antibodies |
10/20/2011 | US20110256153 CD37-Binding Molecules and Immunoconjugates Thereof |
10/20/2011 | US20110256151 Antibodies to human il-1beta |
10/20/2011 | US20110256145 Connective Tissue Growth Factor-3 (CTGF-3) |
10/20/2011 | US20110256138 Amyloid-beta binding proteins |
10/20/2011 | US20110256137 Pharmaceutical composition comprising a bispecific antibody for epcam |
10/20/2011 | US20110256133 Anti-polyubiquitin antibodies and methods of use |
10/20/2011 | US20110256132 Myostatin binding proteins |
10/20/2011 | US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof |
10/20/2011 | US20110256056 Monoclonal Antibodies Against HER2 Antigens, and Uses Therefor |
10/20/2011 | CA2792896A1 Method for the selection of a long-term producing cell |
10/19/2011 | EP2378288A1 Unnatural reactive amino acid genetic code additions |
10/19/2011 | EP2377946A1 Inclusion bodies, bacterial cells and compositions containing them and uses thereof |
10/19/2011 | EP2377943A2 Integrated bio-product production facility and methods related thereto |
10/19/2011 | EP2377932A1 ANTI-Siglec-15 ANTIBODY |
10/19/2011 | EP2377891A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
10/19/2011 | EP2376654A2 Vaccines targeting cellular death receptors |
10/19/2011 | EP2376647A1 Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system |
10/19/2011 | EP1930346B1 Antibody produced using ostrich and method for production thereof |
10/19/2011 | EP1924601B1 Expression of proteins in e.coli |
10/19/2011 | EP1762610B1 Truncated dance, dance complex and method of using these |
10/19/2011 | EP1668136B1 A process for proteolytic cleavage and purification of recombinant proteins produced in plants |
10/19/2011 | EP1451338B1 Recombinant antibodies for the detection and neutralization of anthrax toxin |
10/19/2011 | CN1973037B Process for producing dipeptides or dipeptide derivatives |
10/19/2011 | CN1867669B Method for producing gamma-carboxylated proteins |
10/19/2011 | CN102224244A Gene sensitive to normal-tension glaucoma disease, and use thereof |
10/19/2011 | CN102224242A Novel gene cluster |
10/19/2011 | CN102224238A Non-natural amino acid replication-dependent microorganisms and vaccines |
10/19/2011 | CN102221586A Preparation method of membrane protein polypeptides for improving detection rate of membrane proteins |
10/19/2011 | CN102220402A Method for extracting antibacterial peptide from pearl oyster meat |
10/19/2011 | CN102220401A Method for preparing high quality fish skin collagen peptide |
10/19/2011 | CN102220400A Method for synthesis of glutathione in vitro |
10/19/2011 | CN102220367A Method for increasing yield of antibacterial peptide of bacillus subtilis through overexpression of yerP gene |
10/19/2011 | CN102220366A Method for increasing yield of Bacillus subtilis antimicrobial peptide by overexpression comA gene |
10/19/2011 | CN102220345A Recombinant canine alpha-interferon optimized gene, strain and efficient expression |
10/19/2011 | CN102220241A Cultivated fresh water microalgae and application thereof in production of biodiesel and nervonic acid |
10/19/2011 | CN102219830A Oxidation resisting polypeptide and preparation method thereof |
10/19/2011 | CN102219829A Antioxidant polypeptide prepared by enzymatic hydrolysis of sharkskin collagen with acid protease |
10/19/2011 | CN102219828A Antioxidation polypeptide prepared from sharkskin collagen |
10/19/2011 | CN101775387B Mesoporous titanium dioxide immobilized enzyme and preparation method and application thereof |
10/19/2011 | CN101643767B Method for preparing almond peptide from almond dregs |
10/18/2011 | US8039607 Probe, probe set, probe carrier, and testing method |
10/18/2011 | US8039600 Monoclonal antibodies |
10/18/2011 | US8039599 Rapamycin assay |
10/18/2011 | US8039597 Antibodies and related molecules that bind to 24P4C12 proteins |
10/18/2011 | US8039596 Alpha 5-beta 1 antibodies and their uses |
10/18/2011 | US8039595 Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation |
10/18/2011 | US8039594 Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses |
10/18/2011 | US8039592 Optimized Fc variants and methods for their generation |
10/18/2011 | US8039587 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector |
10/18/2011 | US8039586 Cerebral organic anion transporter and its gene |
10/18/2011 | US8039257 Pre-transplant accomodated organs resistant to anti-donor immunity |
10/18/2011 | US8039241 Thermostable alpha-amylases |
10/18/2011 | US8039236 Process for producing dipeptides |
10/18/2011 | US8039232 Method for producing a dipeptide |
10/18/2011 | US8039231 Methods for enhanced production of bone morphogenetic proteins |
10/18/2011 | US8039230 Selection of host cells expressing protein at high levels |
10/18/2011 | US8039226 Anti NC1 monoclonal antibody |
10/18/2011 | US8039005 Mutant forms of streptolysin O |
10/18/2011 | CA2506329C Candida kefyr cytosine deaminase |
10/18/2011 | CA2465156C Il-21 antagonists |
10/18/2011 | CA2463905C Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property |
10/18/2011 | CA2328515C Continuous in-vitro evolution |
10/18/2011 | CA2323572C Vertebrate patched-2 protein |
10/18/2011 | CA2252986C Process for preparing functional recombinant tissue factor |
10/18/2011 | CA2232237C Reagents and methods useful for detecting diseases of the breast |
10/18/2011 | CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent |
10/13/2011 | WO2011127380A2 Compositions and methods for the prevention of cancer in high risk patients |
10/13/2011 | WO2011127322A1 High mannose glycans |
10/13/2011 | WO2011126238A2 Aboveground organ specific promoters for transforming plants and uses thereof |
10/13/2011 | WO2011125875A1 Novel monoclonal antibody and method for immunoassaying d dimer |
10/13/2011 | WO2011084808A3 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases |
10/13/2011 | WO2010099394A9 Alteration and modulation of protein activity by varying post-translational modification |
10/13/2011 | US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content |
10/13/2011 | US20110252487 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
10/13/2011 | US20110251376 Mammalian Tumor Susceptibility Genes and their Uses |
10/13/2011 | US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor |
10/13/2011 | US20110251108 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
10/13/2011 | US20110250704 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification |
10/13/2011 | US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
10/13/2011 | US20110250644 Feed supplement for mammalian cell culture and methods of use |